376
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Feasibility of Providing Interventions for Injection Drug Users in Pharmacy Settings: A Case Study among San Francisco Pharmacists

, Dr.P.H., M.P.H., , Ph.D. & , Ph.D.

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ludmila N. Bakhireva, Adriana Bautista, Sandra Cano, Shikhar Shrestha, Amy M. Bachyrycz & Theresa H. Cruz. (2018) Barriers and facilitators to dispensing of intranasal naloxone by pharmacists. Substance Abuse 39:3, pages 331-341.
Read now
Amy Bachyrycz, Shikhar Shrestha, Barry E. Bleske, Dale Tinker & Ludmila N. Bakhireva. (2017) Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery. Substance Abuse 38:1, pages 55-60.
Read now

Articles from other publishers (15)

Michael R. Gionfriddo, Katelyn M. Owens, Sarah E. Leist, Luke T. Schrum & Jordan R. Covvey. (2023) Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: A systematic review. Journal of the American Pharmacists Association 63:5, pages 1472-1489.e3.
Crossref
KariLynn Dowling-McClay, Stephanie M. Mathis & Nicholas Hagemeier. (2021) Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake. Exploratory Research in Clinical and Social Pharmacy 4, pages 100088.
Crossref
Lakshmi Ganapathi, Aylur K Srikrishnan, Clarissa Martinez, Gregory M Lucas, Shruti H Mehta, Vinita Verma, Allison M McFall, Kenneth H Mayer, Areej Hassan, Shobini Rajan, Conall O’Cleirigh, Sion Kim Harris & Sunil S Solomon. (2021) Young and invisible: a qualitative study of service engagement by people who inject drugs in India. BMJ Open 11:9, pages e047350.
Crossref
Nicholas E. Hagemeier, KariLynn Dowling-McClay, Mahnaz Baladezaei, Sabrina J. Curtis & Matthew Spence. (2021) Pharmacists’ nonprescription syringe dispensing perceptions and behaviors: A three-state descriptive analysis. Drug and Alcohol Dependence 221, pages 108597.
Crossref
Randy So, Yazid Al Hamarneh, Mark Barnes, Michael A. Beazely, Michael Boivin, Julie Laroche, Harsit Patel, Aaron Sihota, Tim Smith & Ross T. Tsuyuki. (2020) The status of naloxone in community pharmacies across Canada. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 153:6, pages 352-356.
Crossref
Michelle L. Sisson, Kristina B. McMahan, Keith R. Chichester, James W. Galbraith & Karen L. Cropsey. (2019) Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama. International Journal of Drug Policy 74, pages 229-235.
Crossref
Joshua P Havens, Kimberly K Scarsi, Harlan Sayles, Donald G Klepser, Susan Swindells & Sara H Bares. (2019) Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States. Open Forum Infectious Diseases 6:10.
Crossref
Olihe Okoro & Lisa Hillman. (2018) HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health. Journal of the American Pharmacists Association 58:4, pages 412-420.e3.
Crossref
Robin A. Pollini. (2017) Self-reported participation in voluntary nonprescription syringe sales in California’s Central Valley. Journal of the American Pharmacists Association 57:6, pages 677-685.
Crossref
Jeffrey P. Bratberg. (2017) Opioids, naloxone, and beyond: The intersection of medication safety, public health, and pharmacy. Journal of the American Pharmacists Association 57:2, pages S5-S7.
Crossref
François Etcheverrigaray, Céline Bétaud, Fanny Feuillet, Marie Grall-Bronnec, Pascale Jolliet & Caroline Victorri-Vigneau. (2016) Pharmacists’ different profiles characterization about opioid substitution treatments. Therapies 71:4, pages 379-387.
Crossref
Christopher Rowe, Glenn-Milo Santos, Eric Vittinghoff, Eliza Wheeler, Peter Davidson & Philip O. Coffin. (2016) Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths. Journal of Urban Health 93:1, pages 117-130.
Crossref
Yi Yang, Carl Latkin, Rongsheng Luan & Cui Yang. (2016) Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs. International Journal of Drug Policy 27, pages 113-120.
Crossref
Traci C. Green, Emily F Dauria, Jeffrey Bratberg, Corey S. Davis & Alexander Y Walley. (2015) Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm Reduction Journal 12:1.
Crossref
Yi Yang, Carl A. Latkin, Rongsheng Luan & Cui Yang. (2015) A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China. BMC Public Health 15:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.